Curbside Consultation of the Pancreas: 49 Clinical Questions

Scott Tenner, MD, MPH; Alphonso Brown, MD, MS Clin Epi; Frank Gress, MD

Question 40: How Should I Discuss The Risks Of Post-Procedure Pancreatitis With A Patient Whom I Am Consenting For Endoscopic Retrograde Cholangiopancreatography? Do I Really Have To Tell Him He Could Die? (continued)

Susan Ramdhaney, MD; Alphonso Brown, MD, MS Clin Epi

The development of pancreatitis is the most common serious iatrogenic complication following endoscopic retrograde cholangiopancreatography (ERCP). Although previously reported in the 1980s and 1990s to have an incidence of 10% to 15%, recent reports describe the risk of developing pancreatitis after an ERCP less than 3%. Accompanying this decreased incidence is a significant decrease in severity of the acute pancreatitis. The reason for this decrease is several fold—better patient selection, better technique, and improved care following the development of acute pancreatitis…
The GI Bookshelf Related Content